Table 1. Baseline characteristics of study subjects and weight over time.
Baseline characteristics | ||||
---|---|---|---|---|
NB32 |
Placebo |
|||
Mean±s.d. | Range | Mean±s.d. | Range | |
Age (years) | 30.9±7.8 | 20–44 | 31.4±8.5 | 19–45 |
BMI (kg m−2) | 33.0±4.6 | 27.7–40.4 | 32.0±3.2 | 27.3–37.6 |
Weight over time | ||||
|
NB32 |
Placebo |
Placebo-corrected difference |
P-value |
Weight | ||||
Baseline (kg) | 87.9±17.0 | 90.3±14.2 | NA | NA |
% Change at week 4 | −0.99±0.44 | −0.43±0.44 | −0.56 | 0.38 |
Abbreviations: BMI, body mass index; NA, not applicable; NB32, naltrexone-sustained release (SR) 32 mg and bupropion SR 360 mg.
Baseline values are mean±s.d. Changes are least square mean±s.e.
N=20 for both NB32 and placebo groups.